Korro Bio, Inc. Common Stock (KRRO) is a publicly traded Healthcare sector company. As of May 19, 2026, KRRO trades at $9.79 with a market cap of $146.82M and a P/E ratio of -0.85. KRRO moved -4.01% today. Year to date, KRRO is +23.85%; over the trailing twelve months it is -34.02%. Its 52-week range spans $5.20 to $98.00. Analyst consensus is strong buy with an average price target of $20.13. Rallies surfaces KRRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
9 analysts cover KRRO: 0 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $20.13.
| Metric | Value |
|---|---|
| Price | $9.79 |
| Market Cap | $146.82M |
| P/E Ratio | -0.85 |
| EPS | $-11.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $98.00 |
| 52-Week Low | $5.20 |
| Volume | 46.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.84M |
| Net Income | $-113.50M |
| Gross Margin | 0.00% |
9 analysts cover KRRO: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.13.